Customers or research participants?: Guidance for research practices in commercialization of personal genomics

Center for Biomedical Ethics, School of Medicine, Stanford University, Stanford, California, USA.
Genetics in medicine: official journal of the American College of Medical Genetics (Impact Factor: 6.44). 06/2012; 14(10):833-835. DOI: 10.1038/gim.2012.64
Source: PubMed

ABSTRACT Genet Med 2012:14(10):833-835.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The UK National Health Service (the 'NHS'), encouraged by the 2011 report Innovation Health and Wealth, Accelerating Adoption and Diffusion in the NHS, and empowered by the Health and Social Care Act 2012, is in the process of adopting a new agenda for stimulating innovation in healthcare. For this, the bodies, body materials, and confidential health information of NHS patients may be co-opted. We explain why this brings the NHS into a moral conflict with its basic goal of providing a universal healthcare service. Putting NHS databases at the disposal of industry, without addressing ethical concerns regarding the privacy, autonomy, and moral integrity of patients and without requiring a 'kick-back' to enhance the service that the NHS provides, is inappropriate. As this article shows, with reference to the commercial arena of direct-to-consumer genetic testing, it is crucial that patient and public trust in the NHS is not eroded.
    Medical Law Review 05/2014; 22(2):221-37. DOI:10.1093/medlaw/fwu004 · 0.73 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The combination of decreased genotyping costs and prolific social media use is fueling a personal genetic testing industry in which consumers purchase and interact with genetic risk information online. Consumers and their genetic risk profiles are protected in some respects by the 2008 federal Genetic Information Nondiscrimination Act (GINA), which forbids the discriminatory use of genetic information by employers and health insurers; however, practical and technical limitations undermine its enforceability, given the everyday practices of online social networking and its impact on the workplace. In the Web 2.0 era, employers in most states can legally search about job candidates and employees online, probing social networking sites for personal information that might bear on hiring and employment decisions. We examine GINA's protections for online sharing of genetic information as well as its limitations, and propose policy recommendations to address current gaps that leave employees' genetic information vulnerable in a Web-based world.
    The American Journal of Bioethics 11/2014; 14(11):32-44. DOI:10.1080/15265161.2014.957417 · 2.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE: To provide an ethical framework for clinicians and companies providing non-invasive prenatal testing using cell-free fetal DNA or whole fetal cells. METHOD: In collaboration with an NIH-supported research ethics consultation committee, together with feedback from an inter-disciplinary group of clinicians, members of industry, legal experts and genetic counselors we developed a set of best practices for the provision of non-invasive prenatal genetic testing. RESULTS: Principal recommendations include the amendment of current informed consent procedures to include attention to the non-invasive nature of new testing and the potential for a broader range of results earlier in the pregnancy. We strongly recommend that tests should only be provided through licensed medical providers and not direct-to-consumer. CONCLUSION: Prenatal tests, including new methods using cell-free fetal DNA, are not currently regulated by government agencies and limited professional guidance is available. In the absence of regulation, companies and clinicians should cooperate to adopt responsible best ethical practices in the provision of these tests. This article is protected by copyright. All rights reserved.
    Prenatal Diagnosis 07/2013; 33(7). DOI:10.1002/pd.4144 · 2.51 Impact Factor

Full-text (2 Sources)

Available from
Jun 4, 2014